EDAP is the global leader in the area of
medical devices based on High Intensity Focused Ultrasound
(HIFU).
EDAP is an international company headquartered
in Lyon, France. The company is entirely dedicated to the
HIFU technology for the minimally invasive treatment of localized
cancer. The EDAP Research & Development team works closely
together with French Medical Research Institutes in order
to test the feasibility and efficacy of new minimally invasive
treatment methods. The Clinical Studies are conducted internationally
and so is the Marketing of the medical devices.
Due to the unique cooperation between research
teams, doctors and the company, the cutting edge medical
devices marketed by EDAP are developed to respond to patients'
as well as doctors' needs. The results are minimally invasive
treatments that minimize side effects and thus allow for
rapid recovery of the patient.
Conclusive results from the clinical studies
led over the past ten years show that EDAP is today the most
advanced company in therapeutic ultrasound.The Ablatherm,
a HIFU device for the treatment of localized prostate cancer,
is the first HIFU device to have obtained the CE mark in
2000.
EDAP THE HIFU COMPANY also develops the Focalized
Ultrasound technique for the treatment of other cancer pathologies.
Due to large investments in Research & Development, EDAP
ensures its capacity to maintain its position as pioneer
in the area of therapeutic ultrasound. The strong distribution
network reinforces the leadership position of EDAP in the
area of High Intensity Focused Ultrasound.
EDAP SA is an EDAP
TMS company. Listed on the US NASDAQ National Market
System, the Group develops, manufactures and distributes
a portfolio of minimally invasive medical devices mainly
for the treatment of urological diseases.
Click
here for more information on Edap-TMS 